RTA Laboratuvarlari Biyolojik (RTALB) — Cash Flow Quality Index
RTA Laboratuvarlari Biyolojik (RTALB) has a Cash Flow Quality Index of 0.23x as of June 2025. Operating cash flow of TL20.98 Million is below net income of TL91.75 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore RTALB operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
RTA Laboratuvarlari Biyolojik Cash Flow Quality Index (2014–2024)
Historical Cash Flow Quality Index for RTA Laboratuvarlari Biyolojik across 10 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see RTALB cash generation efficiency.
Annual Cash Flow Quality Index for RTA Laboratuvarlari Biyolojik (2014–2024)
Year-by-year earnings quality comparison for RTA Laboratuvarlari Biyolojik.
| Year | Quality Index | Operating CF (TRY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | -1.62x | TL-84.45 Million | TL52.23 Million | ▼ -222.7% |
| 2022 | -0.50x | TL-140.82 Million | TL281.12 Million | ▼ -183.4% |
| 2021 | 0.60x | TL68.78 Million | TL114.47 Million | ▲ +290.7% |
| 2020 | 0.15x | TL9.37 Million | TL60.93 Million | ▼ -81.0% |
| 2019 | 0.81x | TL3.58 Million | TL4.42 Million | ▲ +130.6% |
| 2018 | -2.64x | TL-5.81 Million | TL2.20 Million | ▼ -881.0% |
| 2017 | 0.34x | TL1.41 Million | TL4.16 Million | ▼ -51.7% |
| 2016 | 0.70x | TL2.86 Million | TL4.09 Million | ▼ -15.4% |
| 2015 | 0.83x | TL6.18 Million | TL7.48 Million | ▲ +45.3% |
| 2014 | 0.57x | TL2.58 Million | TL4.54 Million | — |